MARA Holdings
MARA
Microsoft
MSFT
Coinbase
COIN
Tesla
TSLA
Salesforce
CRM
US Stock MarketDetailed Quotes
IVA Inventiva
- 2.490
- -0.040-1.58%
Trading Dec 12 10:10 ET
216.82MMarket Cap-1.15P/E (TTM)
2.650High2.480Low4.78KVolume2.500Open2.530Pre Close12.10KTurnover0.02%Turnover RatioLossP/E (Static)87.08MShares4.75052wk High-2.61P/B61.42MFloat Cap1.53052wk Low--Dividend TTM24.66MShs Float19.064Historical High--Div YieldTTM6.72%Amplitude1.530Historical Low2.528Avg Price1Lot Size
About Inventiva Company
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
Company Profile
SymbolIVA
Company NameInventiva
Issue Price14.40
Founded2011
CEOMr. Frederic Cren
MarketNASDAQ
Employees123
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address50, rue de Dijon
CityDaix
ProvinceBF
CountryFrance
Zip Code21121
Phone33-3-80-44-75-00
Company Executives
- Name
- Position
- Salary
- Frederic Cren
- Chairman of the Board and Chief Executive Officer
- 1.00M
- Dr. Pierre Broqua
- Director, Chief Scientific Officer and Deputy Chief Executive Officer
- 938.43K
- Alice Roudot-Ketelers
- Chief Operating Officer
- --
- Michael Cooreman
- Chief Medical Officer
- --
- Jean Volatier
- Chief Financial Officer and Deputy General Manager
- --
- Dr. Pascaline Clerc, PhD
- Executive Vice President, Strategy and Corporate Affairs
- --
- Martine Zimmermann, Pharm.D.
- Independent Director
- 21.60K
- Dr. Lucy Lu, M.D.
- Independent Director
- 43.20K
- Dr. Annick Schwebig
- Independent Director
- 61.20K
- Heinz Christoph Maeusli
- Independent Director
- 49.20K
- Chris Buyse
- Independent Director
- 61.20K
- Eric Duranson
- General Counsel
- --
- Nathalie Harroy
- Head of Human Resources
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.